RAMM Pharma Corp. announced a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.05 per unit for total gross proceeds of up to CAD 1,000,000 on September 5, 2023. Each unit would have been comprised of one common share in the capital of the company and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share at a price of CAD 0.05 for a period of 36 months following the closing date of the transaction.

The transaction is expected to close on or about September 26, 2023.